A Phase I Pharmacokinetic Study of TVB-2640 (Denifanstat) in Subjects With Mild, Moderate, or Severe Hepatic Impairment Compared to Subjects With Normal Hepatic Function

Clinical trial NCT05835180 · COMPLETED

Trial details

NCT number: NCT05835180
Sponsor: Sagimet Biosciences Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Non-alcoholic Steatohepatitis Hepatic Impairment Cirrhosis

Start date: 2023-05-01
Primary completion: 2023-12-18
Enrollment: 48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.